Keefe Bruyette lowered the firm’s price target on Hercules Capital (HTGC) to $20.50 from $21.50 and keeps an Outperform rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTGC:
- MoonLake Immunotherapeutics secures up to $500M in non-dilutive financing
- Hercules Capital Closes $287.5M Convertible Notes Offering
- Hercules Capital Announces $250M Convertible Notes Offering
- Hercules Capital price target raised to $20 from $18.25 at Compass Point
- Hercules Capital’s Earnings Call Highlights Record Growth